Suchitra Rao1, Kevin Messacar, Michelle R Torok, Anne-Marie Rick, Jeffrey Holzberg, Aaron Montano, Dayanand Bagdure, Donna J Curtis, M Steven Oberste, W Allan Nix, Gina de Masellis, Christine C Robinson, Samuel R Dominguez. 1. 1Department of Pediatrics (Hospital Medicine and Infectious Diseases), University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.2Department of Pediatrics (Hospital Medicine), University of Colorado School of Medicine; Adult and Child Center for Health Outcomes Research and Delivery Science, Aurora, CO.3Department of Pediatrics, University of Colorado School of Medicine, and Children's Hospital Colorado, Aurora, CO.4University of Colorado School of Medicine, Aurora, CO.5Department of Pediatrics (Critical Care), University of Maryland School of Medicine, Baltimore, MD.6Department of Pediatrics (Infectious Diseases), University of Colorado School of Medicine, and Children's Hospital Colorado, Aurora, CO.7Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA.8Department of Pediatrics (Critical Care), University of Colorado School of Medicine, and Children's Hospital Colorado, Aurora, CO.9Department of Microbiology (Virology), Children's Hospital Colorado, Aurora, CO.
Abstract
OBJECTIVE: In 2014, the Unites States experienced an outbreak of enterovirus D68 associated with severe respiratory illness. The clinical characteristics associated with severe illness from enterovirus D68 during this outbreak compared with those associated with the 2009 H1N1 influenza virus outbreak are unknown. DESIGN AND SETTING: In this retrospective cohort study, we characterized the clinical features of children with enterovirus D68 admitted to the PICU between August 1, 2014, and November 1, 2014, and compared them with critically ill children infected with H1N1 influenza during the pandemic admitted between May 1, 2009, and January 31, 2010. PATIENTS: PICU patients. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Ninety-seven severely ill children with enterovirus D68 infections were compared with 68 children infected with H1N1 influenza during the 2009 pandemic. Children with enterovirus D68 were more likely to have asthma (62% vs 23%; p < 0.001) and present with reactive airway disease exacerbations, with greater receipt of albuterol (94% vs 49%) and steroids (89% vs 40%; p < 0.0001 for both). Although more children with enterovirus D68 were admitted to the ICU compared with those with H1N1 influenza, they had a shorter hospital length of stay (4 vs 7 d; p < 0.0001), with lower intubation rates (7% vs 44%), vasopressor use (3% vs 32%), acute respiratory distress syndrome (3% vs 24%), shock (0% vs 16%), and death (0% vs 12%; p < 0.05 for all). Compared with children with other enteroviruses and rhinoviruses, children with enterovirus D68 were more likely to have a history of asthma (64% vs 45%) or multiple prior wheezing episodes (54% vs 34%; p < 0.01 for both). CONCLUSIONS: Critically ill children with enterovirus D68 were more likely to present with reactive airway disease exacerbations, whereas children with H1N1 influenza were more likely to present with pneumonia. Compared with the pandemic H1N1 influenza outbreak, the enterovirus D68 outbreak resulted in more children requiring admission to the ICU, but was associated with less severe outcomes.
OBJECTIVE: In 2014, the Unites States experienced an outbreak of enterovirus D68 associated with severe respiratory illness. The clinical characteristics associated with severe illness from enterovirus D68 during this outbreak compared with those associated with the 2009 H1N1influenza virus outbreak are unknown. DESIGN AND SETTING: In this retrospective cohort study, we characterized the clinical features of children with enterovirus D68 admitted to the PICU between August 1, 2014, and November 1, 2014, and compared them with critically ill children infected with H1N1influenza during the pandemic admitted between May 1, 2009, and January 31, 2010. PATIENTS: PICU patients. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Ninety-seven severely ill children with enterovirus D68 infections were compared with 68 children infected with H1N1influenza during the 2009 pandemic. Children with enterovirus D68 were more likely to have asthma (62% vs 23%; p < 0.001) and present with reactive airway disease exacerbations, with greater receipt of albuterol (94% vs 49%) and steroids (89% vs 40%; p < 0.0001 for both). Although more children with enterovirus D68 were admitted to the ICU compared with those with H1N1influenza, they had a shorter hospital length of stay (4 vs 7 d; p < 0.0001), with lower intubation rates (7% vs 44%), vasopressor use (3% vs 32%), acute respiratory distress syndrome (3% vs 24%), shock (0% vs 16%), and death (0% vs 12%; p < 0.05 for all). Compared with children with other enteroviruses and rhinoviruses, children with enterovirus D68 were more likely to have a history of asthma (64% vs 45%) or multiple prior wheezing episodes (54% vs 34%; p < 0.01 for both). CONCLUSIONS: Critically ill children with enterovirus D68 were more likely to present with reactive airway disease exacerbations, whereas children with H1N1influenza were more likely to present with pneumonia. Compared with the pandemic H1N1influenza outbreak, the enterovirus D68 outbreak resulted in more children requiring admission to the ICU, but was associated with less severe outcomes.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg Journal: Am J Respir Crit Care Med Date: 1994-03 Impact factor: 21.405
Authors: Christopher M Oermann; Jennifer E Schuster; Gregory P Conners; Jason G Newland; Rangaraj Selvarangan; Mary Anne Jackson Journal: Ann Am Thorac Soc Date: 2015-05
Authors: M Steven Oberste; Kaija Maher; David Schnurr; Mary R Flemister; Judith C Lovchik; Heather Peters; Wendy Sessions; Carol Kirk; Nando Chatterjee; Susan Fuller; J Michael Hanauer; Mark A Pallansch Journal: J Gen Virol Date: 2004-09 Impact factor: 3.891
Authors: James W Varni; Christine A Limbers; Katie Neighbors; Kris Schulz; Judith E C Lieu; Robert W Heffer; Krista Tuzinkiewicz; Rita Mangione-Smith; Jerry J Zimmerman; Estella M Alonso Journal: Qual Life Res Date: 2010-08-22 Impact factor: 3.440
Authors: Philip A Chan; Leonard A Mermel; Sarah B Andrea; Russell McCulloh; John P Mills; Ignacio Echenique; Emily Leveen; Natasha Rybak; Cheston Cunha; Jason T Machan; Terrance T Healey; Kimberle C Chapin Journal: PLoS One Date: 2011-09-16 Impact factor: 3.240
Authors: John C Kash; Kathie-Anne Walters; A Sally Davis; Aline Sandouk; Louis M Schwartzman; Brett W Jagger; Daniel S Chertow; Qi Li; Rolf E Kuestner; Adrian Ozinsky; Jeffery K Taubenberger Journal: mBio Date: 2011-09-20 Impact factor: 7.867
Authors: Mark A Poritz; Anne J Blaschke; Carrie L Byington; Lindsay Meyers; Kody Nilsson; David E Jones; Stephanie A Thatcher; Thomas Robbins; Beth Lingenfelter; Elizabeth Amiott; Amy Herbener; Judy Daly; Steven F Dobrowolski; David H-F Teng; Kirk M Ririe Journal: PLoS One Date: 2011-10-19 Impact factor: 3.240
Authors: Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews Journal: Clin Microbiol Rev Date: 2018-12-12 Impact factor: 26.132
Authors: Devendra T Mourya; Pragya D Yadav; P T Ullas; Sumit D Bhardwaj; Rima R Sahay; Mandeep S Chadha; Anita M Shete; Santosh Jadhav; Nivedita Gupta; Raman R Gangakhedkar; Pradeep Khasnobis; Sujeet K Singh Journal: Indian J Med Res Date: 2019-04 Impact factor: 2.375
Authors: Jelte Helfferich; Marjolein Knoester; Coretta C Van Leer-Buter; Rinze F Neuteboom; Linda C Meiners; Hubert G Niesters; Oebele F Brouwer Journal: Eur J Pediatr Date: 2019-07-23 Impact factor: 3.183
Authors: Holly M Biggs; Monica McNeal; W Allan Nix; Carolyn Kercsmar; Aaron T Curns; Beverly Connelly; Marilyn Rice; Shur-Wern Wang Chern; Mila M Prill; Nancy Back; M Steven Oberste; Susan I Gerber; Mary A Staat Journal: Clin Infect Dis Date: 2017-07-15 Impact factor: 9.079
Authors: Marc Desforges; Alain Le Coupanec; Philippe Dubeau; Andréanne Bourgouin; Louise Lajoie; Mathieu Dubé; Pierre J Talbot Journal: Viruses Date: 2019-12-20 Impact factor: 5.048